相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Protein kinase A RI-α predicts for prostate cancer outcome:: Analysis of radiation therapy oncology group trial 86-10
Li-Yan Khor et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)
Antisense-MDM2 sensitizes lncap prostate cancer cells to androgen deprivation, radiation, and the combination in vivo
Radka Stoyanova et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Radiation dose and late failures in prostate cancer
Peter B. Morgan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
The predictive value of 2-year posttreatment biopsy after prostate cancer radiotherapy for eventual biochemical outcome
Waseet Vance et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells
G. Wang et al.
ONCOGENE (2006)
Short hairpin RNA knockdown of the androgen receptor attenuates ligand-independent activation and delays tumor progression
Helen Cheng et al.
CANCER RESEARCH (2006)
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference
Mack Roach et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Amino-terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer
G Wang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Radiosensitization by targeting radioresistance-related genes with protein kinase A inhibitor in radioresistant cancer cells
C Chin et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2005)
Short-term androgen deprivation and radiotherapy for locally advanced prostate cancer: Results from the Trans-Tasman Radiation Oncology Group 96.01 randomised controlled trial
JW Denham et al.
LANCET ONCOLOGY (2005)
Mechanisms of endocrine therapy-responsive and -unresponsive prostate tumours
Z Culig et al.
ENDOCRINE-RELATED CANCER (2005)
The role of protein kinase A pathway and cAMP responsive element-binding protein in androgen receptor-mediated transcription at the prostate-specific antigen locus
J Kim et al.
JOURNAL OF MOLECULAR ENDOCRINOLOGY (2005)
Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic
H Miyake et al.
INTERNATIONAL JOURNAL OF UROLOGY (2005)
Antisense MDM2 sensitizes prostate cancer cells to androgen deprivation, radiation, and the combination
ZM Mu et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Androgen receptor cross-talk with cell signalling pathways
Z Culig
GROWTH FACTORS (2004)
6-month androgen suppression plus radiation therapy vs radiation therapy alone for patients with clinically localized prostate cancer - A randomized controlled trial
AV D'Amico et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Antisense MDM2 oligonucleotides restore the apoptotic response of prostate cancer cells to androgen deprivation
ZM Mu et al.
PROSTATE (2004)
Antisense protein kinase A RIα inhibits 7,12-dimethylbenz(a)anthracene-induction of mammary cancer:: Blockade at the initial phase of carcinogenesis
MV Nesterova et al.
CLINICAL CANCER RESEARCH (2004)
Synergistic antiproliferative and apoptotic effects induced by epidermal growth factor receptor and protein kinase a inhibitors in human prostatic cancer cell lines
M Mimeault et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Practical application of biochemical failure definitions: What to do and when to do it
LL Kestin et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Activation of the androgen receptor N-terminal domain by interleukin-6 via MAPK and STAT3 signal transduction pathways
T Ueda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Pharmocologic inhibitors of the mitogen activated protein kinase cascade have the potential to interact with ionizing radiation exposure to induce cell death in carcinoma cells by multiple mechanisms
L Qiao et al.
CANCER BIOLOGY & THERAPY (2002)
Lack of prostate cancer radiosensitization by androgen deprivation
A Pollack et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Phase III Radiation Therapy Oncology Group (RTOG) trial 86-10 of androgen deprivation adjuvant to definitive radiotherapy in locally advanced carcinoma of the prostate
MV Pilepich et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2001)
Oligonucleotide sequence-specific inhibition of gene expression, tumor growth inhibition, and modulation of cAMP signaling by an RNA-DNA hybrid antisense targeted to protein kinase A RIα subunit
M Nesterova et al.
ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT (2000)